May 1, 2022 - The NASH Podcast - Surfing the NASH Tsunami Podcast

S3-E22.4 – Previewing the 5th Global NASH Congress: Summing Up

Professor Ian Rowe and scientist/entrepreneur Rachel Zayas join the Surfers to preview the 5th Global NASH Congress. This conversation focuses on a range of topics.

May 1, 2022

S3-E22.3 – Previewing the 5th Global NASH Congress: NASH Drug Development Presentations

Professor Ian Rowe and scientist/entrepreneur Rachel Zayas join the Surfers to preview the 5th Global NASH Congress. This conversation focuses on presentations regarding

May 1, 2022

Day: May 1, 2022

All Podcast Categories

S3-E22.4 – Previewing the 5th Global NASH Congress: Summing Up

S3-E22.3 – Previewing the 5th Global NASH Congress: NASH Drug Development Presentations

Discussion Group

Join The Discussion in our LinkedIn or Facebook Discussion Groups

Join The Live Recordings

Recording for this session will take place at 3:15p Eastern US time (1900H CET, 1800H BT) on Monday.

Join The Discussion…

Surfing The NASH Tsunami Podcast

S3-E26 – What Are We Learning About Clinical Trial Best Practices For NITs?

S3-E25.6 – Emerging Concepts In NASH: NAFLD Patient Screening, NASH Management

S3-E25.5 – Emerging Concepts in NASH: Fatty Liver Pathophysiology, Epidemiology, Co-Morbidities

S3-E25.4 – NASH Drug Development in 2022: Will Quality of Life Data Help NASH Drugs Over the Finish Line?

S3-E25.3 – Future NASH Drug Development: More Diverse Trial Populations and More Study of Combination NASH Drugs

S3-E25.2 – NASH Drug Development In 2022: A Wealth of Data and a Promising NASH Pipeline

S3-E25.1 – NASH Drug Development in 2022: Late-Stage NASH Drugs and Their Path to Market

S3-E25 – Crystal Ball Looks at Drug Development and the NASH Pipeline

S3-E24.5 – From #INCBCN: Digital Health and Patient Empowerment: a Conversation with Dr. Marcus Ranney

S3-E24.4 – Innovations in NAFLD Care Conference: What Is the Importance of Steatosis in Metabolic Health?